Targeted Strategies for Today's Evolving Markets

MissionIR Blog

InSite Vision Incorporated (INSV) Starts Presentation at 25th Annual ROTH

InSite Vision is engaged in the advancement of new ophthalmologic products to address unmet eye care needs. The company’s DuraSite and DuraSite 2 drug delivery systems extend drug retention duration on the surface of the eye, reducing the frequency of treatment and improving topical drug efficacy. InSite Vision’s DuraSite platform is currently leveraged in two commercial products, AzaSite and Besivance, and the company is advancing three novel ophthalmic therapeutics through Phase 3 clinical studies. For more information, visit the company’s Web site:

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *